Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma

被引：6
|
作者：
Sinakos, Emmanouil [1 ,2 ]
Dedes, Ioannis [2 ]
Papalavrentios, Lavrentis [1 ,2 ]
Drevelegas, Antonios [1 ,2 ]
Akriviadis, Evangelos [1 ,2 ]
机构：
[1] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece
[2] Interbalkan Med Ctr, Thessaloniki, Greece
来源：
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 45卷 / 04期
关键词：
ANGIOGENESIS; MANAGEMENT; EFFICACY; TRIAL; TACE; HCC;
D O I：
10.3109/00365521003628335
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：511 / 512
页数：2
相关论文
共 50 条
  • [1] Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma
    Tsilimigras, Diamantis I.
    Pawlik, Timothy M.
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (23)
  • [2] Sorafenib in combination with transarterial chemoembolization and radiofrequency ablation in the treatment for unresectable hepatocellular carcinoma
    Li, Yong
    Zheng, You-Bing
    Zhao, Wei
    Liu, Bing
    Hu, Bao-Shan
    He, Xu
    Huang, Jian-Wen
    Lu, Li-Gong
    [J]. MEDICAL ONCOLOGY, 2013, 30 (04)
  • [3] Sorafenib in combination with transarterial chemoembolization and radiofrequency ablation in the treatment for unresectable hepatocellular carcinoma
    Yong Li
    You-Bing Zheng
    Wei Zhao
    Bing Liu
    Bao-Shan Hu
    Xu He
    Jian-Wen Huang
    Li-Gong Lu
    [J]. Medical Oncology, 2013, 30
  • [4] Sorafenib in Combination With Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
    Geschwind, Jean-Francois H.
    Chapiro, Julius
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (08) : 585 - 587
  • [5] THE SAFETY AND EFFICACY OF SORAFENIB COMBINED WITH TRANSARTERIAL CHEMOEMBOLIZATION FOR PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA
    Shao, W.
    Cong, N.
    Song, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 161 - 161
  • [6] Lenvatinib in combination with transarterial chemoembolization vs. sorafenib in combination with transarterial chemoembolization for unresectable hepatocellular carcinoma: A network meta-analysis
    Li, Yong
    Liu, Xingyu
    Liu, Junning
    Yang, Linfeng
    Wei, Song
    Li, Jijiang
    Gan, Huixin
    Ma, Ting
    Yi, Pengsheng
    [J]. ONCOLOGY LETTERS, 2024, 28 (02)
  • [7] Combination of transarterial chemoembolization plus sorafenib in Chinese patients with unresectable hepatocellular carcinoma: A subgroup results of the START final analysis
    Han, G.
    Yang, J.
    Shao, G.
    Teng, G.
    Wang, M.
    Yang, J.
    Liu, Z.
    Feng, G.
    Chao, Y.
    Wang, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S586 - S586
  • [8] The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
    Chen, Lei
    Sun, Tao
    Wu, Linxia
    Zhang, Weihua
    Ren, Yanqiao
    Xiang, Dongqiao
    Liang, Bin
    Zheng, Chuansheng
    [J]. JOURNAL OF ONCOLOGY, 2021, 2021
  • [9] Transarterial chemoembolization and sorafenib in hepatocellular carcinoma
    Cabibbo, Giuseppe
    Tremosini, Silvia
    Galati, Giovanni
    Mazza, Giancarlo
    Gadaleta-Caldarola, Gennaro
    Lombardi, Giuseppe
    Antonucci, Michela
    Sacco, Rodolfo
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (07) : 831 - 845
  • [10] Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis
    Li, Lin
    Zhao, Wenzhuo
    Wang, Mengmeng
    Hu, Jie
    Wang, Enxin
    Zhao, Yan
    Liu, Lei
    [J]. BMC GASTROENTEROLOGY, 2018, 18
12345